Symbols / CNMD Stock $38.10 +2.09% CONMED Corporation

Healthcare • Medical Devices • United States • NYQ
CNMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Patrick J. Beyer
Exch · Country NYQ · United States
Market Cap 1.15B
Enterprise Value 1.97B
Income 54.85M
Sales 1.37B
FCF (ttm) 116.49M
Book/sh 33.36
Cash/sh 1.16
Employees 3,900
Insider 10d —
IPO Jul 23, 1987
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 22.60%
P/E 21.53
Forward P/E 7.86
PEG 1.84
P/S 0.84
P/B 1.14
P/C —
EV/EBITDA 10.08
EV/Sales 1.44
Quick Ratio 0.90
Current Ratio 2.29
Debt/Eq 84.59
LT Debt/Eq —
EPS (ttm) 1.77
EPS next Y 4.85
EPS Growth 136.80%
Revenue Growth -1.30%
EPS Gr Q/Q 129.10%
Rev Gr Q/Q —
Earnings (next) 2026-04-29
Earnings (prior) 2026-04-29
ROA 3.31%
ROE 5.50%
ROIC —
Gross Margin 54.06%
Oper. Margin 5.28%
Profit Margin 4.00%
Shs Outstand 30.11M
Shs Float 29.83M
Insider Own 0.41%
Instit Own 114.80%
Short Float 9.10%
Short Ratio 5.60
Short Interest 2.31M
52W High 61.08
vs 52W High -37.62%
52W Low 33.21
vs 52W Low 14.72%
Beta 0.94
Impl. Vol. 52.73%
Rel Volume 0.82
Avg Volume 453.77K
Volume 373.63K
Target (mean) $42.00
Tgt Median $40.00
Tgt Low $39.00
Tgt High $52.00
# Analysts 5
Recom Hold
Prev Close $37.32
Price $38.10
Change 2.09%
About

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$42.00
Mean price target
2. Current target
$38.10
Latest analyst target
3. DCF / Fair value
$69.64
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$38.10
Low
$39.00
High
$52.00
Mean
$42.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-01 main Wells Fargo Equal-Weight → Equal-Weight $39
2026-04-30 main JP Morgan Neutral → Neutral $40
2026-03-17 down Piper Sandler Overweight → Neutral $39
2026-01-29 main Wells Fargo Equal-Weight → Equal-Weight $42
2026-01-29 reit Needham Hold → Hold —
2025-12-08 main B of A Securities Neutral → Neutral $52
2025-11-06 main JP Morgan Neutral → Neutral $52
2025-11-06 main Piper Sandler Overweight → Overweight $55
2025-11-06 main Wells Fargo Equal-Weight → Equal-Weight $47
2025-07-31 main Piper Sandler Overweight → Overweight $68
2025-06-12 down Needham Buy → Hold $61
2025-05-01 main JP Morgan Neutral → Neutral $58
2025-05-01 main Wells Fargo Equal-Weight → Equal-Weight $57
2025-05-01 main Needham Buy → Buy $61
2025-04-28 down Stifel Buy → Hold $55
2025-02-06 main Stifel Buy → Buy $75
2025-02-06 main Wells Fargo Equal-Weight → Equal-Weight $70
2025-02-06 main Needham Buy → Buy $91
2025-02-06 down JP Morgan Overweight → Neutral $70
2024-10-31 reit Needham Buy → Buy $97
News
RSS: Latest CNMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 LALOMIA BRENT Officer — 75 — —
2026-02-24 KAYE MARK Director — 152 — —
2025-11-21 GLAZE RICHARD Chief Technology Officer — 257 $41.21 $10,591
2025-11-20 GLAZE RICHARD Chief Technology Officer — 375 — —
2025-11-06 GARNER TODD W. Chief Financial Officer — 3,500 $43.00 $150,500
2025-11-04 FOUST HOLLIE K General Counsel — 4,000 — —
2025-10-31 GARNER TODD W. Chief Financial Officer — 7,500 — —
2025-09-12 FARKAS CHARLES M Director — 2,000 $53.51 $107,049
2025-08-07 GARNER TODD W. Chief Financial Officer — 598 $52.45 $31,365
2025-06-03 COUNCIL LAVERNE H. Director — 479 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,374.72
+5.18%
1,307.02
+5.00%
1,244.74
+19.06%
1,045.47
Operating Revenue
1,374.72
+5.18%
1,307.02
+5.00%
1,244.74
+19.06%
1,045.47
Cost Of Revenue
624.25
+8.76%
573.98
+0.96%
568.50
+19.88%
474.23
Reconciled Cost Of Revenue
624.25
+8.76%
573.98
+0.96%
568.50
+19.88%
474.23
Gross Profit
750.48
+2.38%
733.03
+8.40%
676.25
+18.38%
571.25
Operating Expense
647.85
+21.62%
532.71
-4.13%
555.64
+10.86%
501.19
Research And Development
55.88
+2.68%
54.43
+3.47%
52.60
+11.56%
47.15
Selling General And Administration
591.97
+23.77%
478.28
-4.92%
503.04
+10.79%
454.04
Total Expenses
1,272.10
+14.95%
1,106.69
-1.55%
1,124.14
+15.25%
975.42
Operating Income
102.62
-48.77%
200.33
+66.10%
120.60
+72.16%
70.05
Total Operating Income As Reported
102.62
-48.77%
200.33
+66.10%
120.60
+72.16%
70.05
EBITDA
176.49
-35.16%
272.18
+41.41%
192.48
+598.34%
27.56
Normalized EBITDA
176.49
-35.16%
272.18
+41.41%
192.48
+598.34%
27.56
Reconciled Depreciation
74.28
+3.37%
71.86
-0.02%
71.87
+3.39%
69.52
EBIT
102.20
-48.98%
200.33
+66.10%
120.60
+387.44%
-41.96
Net Income
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Pretax Income
71.12
-56.38%
163.03
+101.70%
80.83
+214.06%
-70.86
Net Non Operating Interest Income Expense
-31.09
+16.65%
-37.30
+6.23%
-39.77
-37.61%
-28.91
Interest Expense Non Operating
31.09
-16.65%
37.30
-6.23%
39.77
+37.61%
28.91
Net Interest Income
-31.09
+16.65%
-37.30
+6.23%
-39.77
-37.61%
-28.91
Interest Expense
31.09
-16.65%
37.30
-6.23%
39.77
+37.61%
28.91
Other Income Expense
-0.42
—
—
-112.01
Other Non Operating Income Expenses
-0.42
—
—
-112.01
Tax Provision
24.06
-21.38%
30.61
+86.98%
16.37
+68.41%
9.72
Tax Rate For Calcs
0.00
+80.23%
0.00
-7.52%
0.00
-3.33%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Net Income From Continuing Operation Net Minority Interest
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Net Income From Continuing And Discontinued Operation
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Net Income Continuous Operations
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Normalized Income
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Net Income Common Stockholders
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Diluted EPS
1.51
-64.47%
4.25
+108.33%
2.04
+176.12%
-2.68
Basic EPS
1.52
-64.57%
4.29
+104.29%
2.10
+178.36%
-2.68
Basic Average Shares
31.04
+0.62%
30.85
+0.58%
30.67
+2.09%
30.04
Diluted Average Shares
31.15
0.00%
31.15
-1.26%
31.55
+5.02%
30.04
Diluted NI Availto Com Stockholders
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,325.75
+0.85%
2,306.25
+0.27%
2,300.02
+0.11%
2,297.59
Current Assets
672.86
+5.13%
640.01
+3.96%
615.65
+5.92%
581.23
Cash Cash Equivalents And Short Term Investments
40.82
+66.88%
24.46
+0.67%
24.30
-16.05%
28.94
Cash And Cash Equivalents
40.82
+66.88%
24.46
+0.67%
24.30
-16.05%
28.94
Receivables
247.83
+4.25%
237.73
-1.88%
242.28
+26.62%
191.34
Accounts Receivable
247.83
+4.25%
237.73
-1.88%
242.28
+26.62%
191.34
Gross Accounts Receivable
254.13
+4.38%
243.47
-1.95%
248.31
+26.14%
196.85
Allowance For Doubtful Accounts Receivable
-6.30
-9.78%
-5.74
+4.89%
-6.03
-9.55%
-5.51
Inventory
355.54
+2.55%
346.72
+8.92%
318.32
-4.21%
332.32
Raw Materials
109.63
-4.44%
114.73
+6.96%
107.26
-3.09%
110.68
Work In Process
33.26
+6.27%
31.30
+6.23%
29.46
+12.60%
26.17
Finished Goods
212.65
+5.96%
200.69
+10.51%
181.60
-7.10%
195.48
Prepaid Assets
—
—
—
—
Other Current Assets
28.67
-7.80%
31.10
+1.13%
30.75
+7.45%
28.62
Total Non Current Assets
1,652.89
-0.80%
1,666.24
-1.08%
1,684.37
-1.86%
1,716.37
Net PPE
113.33
-2.13%
115.79
-4.08%
120.72
+4.42%
115.61
Gross PPE
429.96
+2.08%
421.21
+2.02%
412.88
+5.02%
393.15
Accumulated Depreciation
-316.63
-3.67%
-305.42
-4.54%
-292.16
-5.27%
-277.54
Properties
0.00
0.00
0.00
0.00
Land And Improvements
4.03
+0.00%
4.03
+0.00%
4.03
+0.00%
4.03
Buildings And Improvements
104.48
+3.51%
100.94
+0.64%
100.30
+3.17%
97.21
Machinery Furniture Equipment
299.18
+1.13%
295.84
+4.36%
283.47
+5.09%
269.75
Construction In Progress
22.27
+9.10%
20.41
-18.65%
25.09
+13.21%
22.16
Goodwill And Other Intangible Assets
1,389.06
-2.39%
1,423.02
-2.29%
1,456.33
-2.73%
1,497.23
Goodwill
807.01
+0.21%
805.36
-0.18%
806.84
-1.05%
815.43
Other Intangible Assets
582.05
-5.77%
617.66
-4.90%
649.48
-4.74%
681.80
Non Current Deferred Assets
13.31
+20.24%
11.07
-1.27%
11.21
+16.18%
9.65
Non Current Deferred Taxes Assets
13.31
+20.24%
11.07
-1.27%
11.21
+16.18%
9.65
Other Non Current Assets
137.19
+17.90%
116.36
+21.07%
96.11
+2.38%
93.88
Total Liabilities Net Minority Interest
1,292.65
-3.79%
1,343.57
-8.34%
1,465.80
-5.56%
1,552.05
Current Liabilities
315.04
+13.27%
278.13
-10.49%
310.73
+4.78%
296.55
Payables And Accrued Expenses
93.65
-8.41%
102.25
+15.90%
88.22
+20.21%
73.39
Payables
93.65
-8.41%
102.25
+15.90%
88.22
+20.21%
73.39
Accounts Payable
93.65
-8.41%
102.25
+15.90%
88.22
+20.21%
73.39
Pensionand Other Post Retirement Benefit Plans Current
82.14
+25.66%
65.37
-6.71%
70.07
+28.02%
54.73
Current Debt And Capital Lease Obligation
0.71
-0.42%
0.71
+0.99%
0.71
-98.98%
69.75
Current Debt
0.71
-0.42%
0.71
+0.99%
0.71
-98.98%
69.75
Other Current Liabilities
138.54
+26.18%
109.80
-27.63%
151.73
+53.76%
98.68
Total Non Current Liabilities Net Minority Interest
977.61
-8.24%
1,065.44
-7.76%
1,155.07
-8.00%
1,255.49
Long Term Debt And Capital Lease Obligation
834.23
-7.83%
905.07
-7.00%
973.14
-1.21%
985.08
Long Term Debt
834.23
-7.83%
905.07
-7.00%
973.14
-1.21%
985.08
Non Current Deferred Liabilities
79.53
+7.36%
74.08
+21.63%
60.90
-8.73%
66.72
Non Current Deferred Taxes Liabilities
79.53
+7.36%
74.08
+21.63%
60.90
-8.73%
66.72
Other Non Current Liabilities
63.85
-26.01%
86.29
-28.70%
121.03
-40.58%
203.69
Stockholders Equity
1,033.10
+7.31%
962.68
+15.40%
834.22
+11.89%
745.54
Common Stock Equity
1,033.10
+7.31%
962.68
+15.40%
834.22
+11.89%
745.54
Capital Stock
0.31
+0.00%
0.31
+0.00%
0.31
+0.00%
0.31
Common Stock
0.31
+0.00%
0.31
+0.00%
0.31
+0.00%
0.31
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
31.30
+0.00%
31.30
+0.00%
31.30
+0.00%
31.30
Ordinary Shares Number
30.97
+0.23%
30.90
+0.44%
30.77
+0.91%
30.49
Treasury Shares Number
0.33
-17.53%
0.40
-25.49%
0.53
-34.20%
0.81
Additional Paid In Capital
503.20
+5.59%
476.57
+6.73%
446.54
+8.06%
413.24
Retained Earnings
588.77
+5.08%
560.28
+23.81%
452.53
+9.67%
412.63
Gains Losses Not Affecting Retained Earnings
-46.30
+21.34%
-58.86
-17.32%
-50.17
+13.29%
-57.86
Treasury Stock
12.89
-17.53%
15.63
+4.27%
14.99
-34.20%
22.78
Other Equity Adjustments
-46.30
+21.34%
-58.86
-17.32%
-50.17
+13.29%
-57.86
Total Equity Gross Minority Interest
1,033.10
+7.31%
962.68
+15.40%
834.22
+11.89%
745.54
Total Capitalization
1,867.33
-0.02%
1,867.75
+3.34%
1,807.36
+4.43%
1,730.62
Working Capital
357.82
-1.12%
361.88
+18.68%
304.92
+7.11%
284.67
Invested Capital
1,868.04
-0.02%
1,868.46
+3.34%
1,808.07
+0.43%
1,800.37
Total Debt
834.94
-7.82%
905.78
-6.99%
973.85
-7.68%
1,054.82
Net Debt
794.12
-9.89%
881.32
-7.19%
949.55
-7.44%
1,025.88
Net Tangible Assets
-355.96
+22.67%
-460.34
+26.00%
-622.11
+17.24%
-751.68
Tangible Book Value
-355.96
+22.67%
-460.34
+26.00%
-622.11
+17.24%
-751.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
170.69
+2.23%
166.97
+33.20%
125.35
+275.69%
33.37
Cash Flow From Continuing Operating Activities
170.69
+2.23%
166.97
+33.20%
125.35
+275.69%
33.37
Net Income From Continuing Operations
47.05
-64.47%
132.42
+105.44%
64.46
+179.99%
-80.58
Depreciation Amortization Depletion
74.28
+3.37%
71.86
-0.02%
71.87
+3.39%
69.52
Depreciation
17.14
+3.24%
16.61
+2.50%
16.20
+0.90%
16.05
Amortization Cash Flow
57.14
+3.41%
55.25
-0.76%
55.67
+4.13%
53.46
Depreciation And Amortization
74.28
+3.37%
71.86
-0.02%
71.87
+3.39%
69.52
Amortization Of Intangibles
57.14
+3.41%
55.25
-0.76%
55.67
+4.13%
53.46
Other Non Cash Items
28.60
+180.90%
-35.35
-1071.90%
3.64
-96.71%
110.55
Stock Based Compensation
28.32
+10.82%
25.56
+5.36%
24.26
+11.63%
21.73
Asset Impairment Charge
—
—
—
—
Deferred Tax
3.52
-71.13%
12.20
+1643.14%
0.70
+111.59%
-6.04
Deferred Income Tax
3.52
-71.13%
12.20
+1643.14%
0.70
+111.59%
-6.04
Operating Gains Losses
0.36
—
—
8.89
Change In Working Capital
-11.45
+71.17%
-39.72
-0.37%
-39.58
+56.36%
-90.70
Change In Receivables
-2.36
-45.83%
-1.62
+96.56%
-47.07
-804.63%
-5.20
Changes In Account Receivables
-2.36
-45.83%
-1.62
+96.56%
-47.07
-804.63%
-5.20
Change In Inventory
-6.73
+78.72%
-31.63
-324.81%
14.07
+117.91%
-78.56
Change In Payables And Accrued Expense
5.16
-56.53%
11.88
-59.42%
29.27
+120.07%
13.30
Change In Accrued Expense
14.91
+626.22%
-2.83
-119.65%
14.43
—
Change In Payable
-9.75
-166.26%
14.71
-0.92%
14.85
+11.63%
13.30
Change In Account Payable
-9.75
-166.26%
14.71
-0.92%
14.85
+11.63%
13.30
Change In Other Working Capital
-0.56
-189.12%
-0.19
+95.08%
-3.92
-74.89%
-2.24
Change In Other Current Assets
-13.16
+5.40%
-13.91
+36.32%
-21.84
-23.17%
-17.73
Change In Other Current Liabilities
6.19
+245.81%
-4.25
+57.90%
-10.09
-3841.41%
-0.26
Investing Cash Flow
-20.96
-60.17%
-13.08
+34.68%
-20.03
+91.97%
-249.53
Cash Flow From Continuing Investing Activities
-20.96
-60.17%
-13.08
+34.68%
-20.03
+91.97%
-249.53
Net PPE Purchase And Sale
-19.81
-51.38%
-13.08
+31.25%
-19.03
+12.64%
-21.79
Purchase Of PPE
-19.81
-51.38%
-13.08
+31.25%
-19.03
+12.64%
-21.79
Sale Of PPE
—
—
—
0.00
Capital Expenditure
-19.81
-51.38%
-13.08
+31.25%
-19.03
+12.64%
-21.79
Net Business Purchase And Sale
—
0.00
0.00
+100.00%
-227.74
Purchase Of Business
—
0.00
0.00
+100.00%
-227.74
Net Other Investing Changes
-1.15
—
-1.00
—
Financing Cash Flow
-135.82
+10.05%
-151.00
-36.74%
-110.43
-149.08%
225.00
Cash Flow From Continuing Financing Activities
-135.82
+10.05%
-151.00
-36.74%
-110.43
-149.08%
225.00
Net Issuance Payments Of Debt
-74.59
-3.59%
-72.00
+18.18%
-88.00
-124.31%
362.02
Issuance Of Debt
720.67
-4.04%
751.00
+8.53%
692.00
-45.08%
1,260.00
Repayment Of Debt
-795.25
+3.37%
-823.00
-5.51%
-780.00
+13.14%
-897.98
Long Term Debt Issuance
720.67
-4.04%
751.00
+8.53%
692.00
-45.08%
1,260.00
Long Term Debt Payments
-795.25
+3.37%
-823.00
-5.51%
-780.00
+13.14%
-897.98
Net Long Term Debt Issuance
-74.59
-3.59%
-72.00
+18.18%
-88.00
-124.31%
362.02
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Common Stock Dividend Paid
-24.75
-0.39%
-24.65
-0.61%
-24.50
-2.26%
-23.96
Cash Dividends Paid
-24.75
-0.39%
-24.65
-0.61%
-24.50
-2.26%
-23.96
Proceeds From Stock Option Exercised
—
0.00
0.00
-100.00%
2.47
Net Other Financing Charges
-36.49
+32.87%
-54.35
-2725.56%
2.07
+101.79%
-115.53
Changes In Cash
13.91
+382.42%
2.88
+156.37%
-5.12
-157.90%
8.84
Effect Of Exchange Rate Changes
2.44
+189.86%
-2.72
-678.94%
0.47
+163.43%
-0.74
Beginning Cash Position
24.46
+0.67%
24.30
-16.05%
28.94
+38.83%
20.85
End Cash Position
40.82
+66.88%
24.46
+0.67%
24.30
-16.05%
28.94
Free Cash Flow
150.88
-1.95%
153.88
+44.74%
106.32
+818.10%
11.58
Interest Paid Supplemental Data
25.42
-22.16%
32.65
-3.07%
33.69
+29.16%
26.08
Income Tax Paid Supplemental Data
—
15.22
-23.43%
19.88
+119.08%
9.07
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category